Shareprice
31 Jan 2026

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2026

21 January, 2026 FluoGuide submits an IND for FG001, to initiate first U.S. registration trial News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark, 21 January 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

2025

19 December, 2025 FluoGuide updates IND submission timing for FG001 – trial initiation unaffected News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark, 19 December 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
27 November, 2025 FluoGuide A/S publishes Interim Report Q3 2025 News English Regulatory Listing Regulation Report Interim Q3 IR
Copenhagen, Denmark, 27 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
25 November, 2025 FluoGuide signs collaboration agreement with ZEISS News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark, 25 November 2025 – FluoGuide A/S, a biotech company specializing in precision cancer surgery, announces...
24 November, 2025 Minutes from Extraordinary General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR
Copenhagen, Denmark, 24 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held an extraordinary...
24 November, 2025 Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 27 November 2025 News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
FluoGuide A/S will publish its Interim Report Q3 2025 on Thursday 27 November 2025. The following event will take place later that...
5 November, 2025 FluoGuide strengthens leadership to advance clinical program and regulatory approval strategy News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
5 November, 2025 FluoGuide convenes an extraordinary general meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
3 November, 2025 FluoGuide A/S issue warrants to board members, executive management and employees News Corporate Action Other mfn-ext-nq mfn-ext-nq-corporate-action English Regulatory Listing Regulation IR
Copenhagen, Denmark, 3 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that it...

FluoGuideCalendar & events